SPSY.L

Spectra Systems Corporation
Spectra Systems - Annual General Meeting Lack of Quorum
30th July 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 2905Y
Spectra Systems Corporation
30 July 2024
 

Spectra Systems Corporation

("The Company" or "Spectra")

Annual General Meeting Lack of Quorum, Removal of Regulation S restrictions from shares and Exercise of Options

Spectra (AIM: SPSY.L) announces that, having received only 8 ballots, it does not have enough shareholder votes to achieve a quorum to transact business at its scheduled 2024 Annual General Meeting on 29 July 2024. The presence in person or by proxy, duly authorized, of the holders of a majority of the outstanding shares of stock entitled to vote constitutes a quorum.

A summary of the votes received is as follows:

Resolution

For

Against

Discretion

Withheld

Total

Elect BJ Penn as Director

 

12,162,853

 

 

1,300,348

-

-

 

13,463,201

 

Elect Nabil Lawandy as Director

 

13,462,853

 

348

-

-

 

13,463,201

 

Elect Jeremy Fry as Director

 

12,162,853

 

 

1,300,348

-

-

 

13,463,201

 

Elect Donald Stanford as Director

 

12,162,853

 

 

1,300,348

-

-

 

13,463,201

 

Elect Barbara Paldus as Director

 

12,162,853

 

 

1,300,348

-


 

13,463,201

Ratification of Appointment of Independent Auditor

 

10,417,053

 

 

1,320,348

 

-

 

1,725,800

 

 

11,737,401

 

 

Total shares of stock outstanding as of the record date of  28 June 2024 was 48,228,972. Therefore, only approximately 28% of the shares of stock were voted.     

Removal of Regulation S restrictions from shares

Restrictive legends have also been removed from a further 36,072 shares of common stock of the Company.

As a result, these share have transferred from the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC) into the unrestricted line ISIN number US84756T1060 (AIM:SPSY).

Exercise of Options     

An employee has exercised options over 10,000 shares of common stock of $0.01 each in the Company ("Shares") with an exercise price of $0.32 per share on 3 June 2024. The employee has elected to utilize the net cashless exercise feature and has therefore surrendered 1,105 shares to the Company. The employee will be issued 8,995 shares. The shares being issued are restricted securities as defined in Rule 144 of the US Securities Act of 1933 and have been issued pursuant to an exemption from registration under Rule 701 promulgated under the US Securities Act of 1933.

Accordingly the Company has issued and will apply for 8,995 shares to be admitted to trading on AIM, which is expected to take place on or around 2 August 2024 ("Admission").     

Following Admission the Company's issued share capital will comprise:

· 752,618 shares in the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC); and

· 47,476,354 shares in the unrestricted line ISIN number US84756T1060 (AIM:SPSY).

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA ("DTRs"), the issued share capital of Spectra upon Admission is 48,228,972 shares with voting rights attached (one vote per share). There are no shares held in treasury, therefore this figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Spectra under the DTRs.

Enquiries:

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

                         

Tel: +1 (0)401 274 4700

 

Zeus Capital Limited (Nominated Adviser and Broker)

Chris Fielding (Head of Corporate Finance)

Andrew de Andrade (Executive, Corporate Finance) 

 

Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 3829 5000

 

 

 

Tel: +44 (0)20 3328 5665

 

               

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGQKCBPCBKDDOB]]>
TwitterFacebookLinkedIn